The Magic Of Brilliant Violet 421™ Anti-mouse Cd135 Certified [VR8tcuQl]

Brilliant Violet 421™ Anti-Mouse CD135

Discover the power of the The Magic Of Brilliant Violet 421™ Anti-mouse Cd135 Certified [VR8tcuQl], a cutting-edge monoclonal antibody designed for fluorescent flow cytometry. This reagent is specifically engineered to target the CD135 molecule, also known as Flk-2, Flt3, and Ly-72, a crucial type III tyrosine kinase receptor expressed on early B lymphoid lineage cells and primitive myeloid progenitors. With its exceptional fluorescent properties and high specificity, this antibody is a valuable tool for researchers investigating hematopoietic stem cell growth, dendritic cell development, and B-cell differentiation.

• Highly specific binding to CD135
• Excellent fluorescent properties for flow cytometry
• Enhanced visualization and analysis of hematopoietic cells

Product Specifications

The The Magic Of Brilliant Violet 421™ Anti-mouse Cd135 Certified [VR8tcuQl] is a monoclonal antibody with a rat host and IgG2a κ isotype. It is formatted in BV421, a vibrant fluorescent dye that provides superior brightness and reduced crosstalk. This antibody has been quality tested for flow cytometry applications, ensuring reliable and consistent results. Key features include:

• Clone: A2F10
• Antibody Type: Monoclonal
• Reactivity: Mouse
• Format: BV421
• Host: Rat
• Isotype: IgG2a, κ

This product is regulated as RUO (Research Use Only) and is supplied by BioLegend, Inc.

Applications and Benefits

The The Magic Of Brilliant Violet 421™ Anti-mouse Cd135 Certified [VR8tcuQl] is an indispensable tool for researchers in the fields of immunology, hematology, and stem cell biology. Its ability to selectively target CD135-expressing cells makes it ideal for various applications, including:

• Analysis of hematopoietic stem cell populations
• Studying dendritic cell development and function
• Investigating B-cell differentiation and commitment

By using this antibody, researchers can gain deeper insights into the complex processes of hematopoiesis and immune system development, leading to advancements in therapeutic strategies and disease understanding.